Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents disaggregated revenue by major product and service categories:

(in thousands)	For the Three Months Ended March 31,
	2023		2022
CAG segment revenue:
CAG Diagnostics recurring revenue:	$	726,902	$	664,810
IDEXX VetLab consumables	291,114		267,173
Rapid assay products	82,032		74,519
Reference laboratory diagnostic and consulting services	323,180		295,075
CAG Diagnostics services and accessories	30,576		28,043
CAG Diagnostics capital - instruments	33,144		36,997
Veterinary software, services and diagnostic imaging systems	67,233		59,377
CAG segment revenue	827,279		761,184
Water segment revenue	38,883		36,371
LPD segment revenue	29,208		30,870
Other segment revenue	4,825		8,124
Total revenue	$	900,195	$	836,549

Revenue by principal geographic area, based on customers’ domiciles, was as follows:

(in thousands)	For the Three Months Ended March 31,
	2023		2022
United States	$	590,413	$	525,906
Europe, the Middle East and Africa	176,008		173,808
Asia Pacific Region	78,360		83,861
Canada	35,962		35,232
Latin America & Caribbean	19,452		17,742
Total revenue	$	900,195	$	836,549